| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-2478(97)00049-7 |
| P698 | PubMed publication ID | 9232420 |
| P2093 | author name string | Mehtali M | |
| Stoeckel F | |||
| Christ M | |||
| Pavirani A | |||
| Lusky M | |||
| Dieterlé A | |||
| Michou AI | |||
| Dreyer D | |||
| P2860 | cites work | Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 |
| Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses | Q35837026 | ||
| Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. | Q35871002 | ||
| Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ | Q35875594 | ||
| Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression | Q36051171 | ||
| Adenovirus as an expression vector in muscle cells in vivo | Q36910386 | ||
| Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors | Q40942254 | ||
| Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver | Q41245959 | ||
| Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses | Q41342232 | ||
| Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice | Q41572953 | ||
| Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. | Q43984256 | ||
| Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenovirus-mediated in vivo gene transfer to mouse synovium. | Q44809129 | ||
| Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. | Q45270141 | ||
| Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration | Q45866667 | ||
| Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. | Q45870000 | ||
| CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. | Q45878144 | ||
| In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector | Q45878932 | ||
| In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes | Q45879411 | ||
| Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. | Q45880303 | ||
| Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung | Q45880309 | ||
| Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression | Q45883263 | ||
| Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig | Q56908863 | ||
| Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer | Q57043072 | ||
| [Genetic therapy for hemophiliacs--therapeutic potential and technological limits] | Q64382571 | ||
| Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial | Q64382613 | ||
| Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors | Q64382915 | ||
| Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector | Q64383065 | ||
| P433 | issue | 1-3 | |
| P921 | main subject | Adenoviridae | Q193447 |
| gene therapy | Q213901 | ||
| P304 | page(s) | 19-25 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | immunology Letters | Q15766068 |
| P1476 | title | Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response | |
| P478 | volume | 57 |
| Q45879506 | A realistic chance for gene therapy in the near future |
| Q42412771 | Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma |
| Q42148836 | Adenoviral vector-mediated overexpression of osteoprotegerin accelerates osteointegration of titanium implants in ovariectomized rats |
| Q46070218 | Adenoviral-mediated transfer of tissue plasminogen activator gene into brain capillary endothelial cells in vitro |
| Q34070158 | Adenovirus vectors for human gene therapy |
| Q44211017 | Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats |
| Q45864746 | Cotransfection of heme oxygenase-1 prevents the acute inflammation elicited by a second adenovirus |
| Q40625018 | Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1. |
| Q38321960 | De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications |
| Q40669254 | Development of an Ad7 cosmid system and generation of an Ad7deltaE1deltaE3HIV(MN) env/rev recombinant virus |
| Q39926337 | Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer |
| Q51728843 | Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death. |
| Q60858602 | Efficient genetic modification of murine dendritic cells by electroporation with mRNA |
| Q45879455 | Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies |
| Q91938470 | Gene Therapy Tools for Brain Diseases |
| Q74822016 | Gene therapy for lung cancer |
| Q36922247 | Gene therapy of gynaecological diseases |
| Q36464907 | Gene transfer approaches for gynecological diseases |
| Q44065907 | Gene transfer mediated by different viral vectors following direct cannulation of mouse submandibular salivary glands |
| Q34731216 | High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets. |
| Q35907018 | Human cancer gene therapy with cytokine gene-modified cells |
| Q35749783 | Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion. |
| Q33782356 | In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. |
| Q40616709 | In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses |
| Q37128807 | In vivo gene delivery with L-tyrosine polyphosphate nanoparticles |
| Q45883079 | In vivo transduction of thymic dendritic cells with adenovirus and its potential use in acute inflammatory diseases |
| Q45890218 | Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells |
| Q39502394 | Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors |
| Q45871871 | Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys. |
| Q44391669 | Insight into antibody responses induced by plasmid or adenoviral vectors encoding thyroid peroxidase, a major thyroid autoantigen |
| Q45865133 | Intramarrow bone morphogenetic protein 4 gene delivery improves local bone quality in femurs of ovariectomized rabbits. |
| Q35110929 | Lentivirus vector-mediated gene transduction of CNGRC peptide in rat adipose stem cells |
| Q60911893 | Microbubble-mediated delivery of human adenoviruses does not elicit innate and adaptive immunity response in an immunocompetent mouse model of prostate cancer |
| Q34697474 | Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide |
| Q33786676 | Myocardial protection: is there a role for gene therapy? |
| Q51191793 | Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo. |
| Q37805248 | Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination |
| Q39601057 | Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E. |
| Q30311916 | Rat strain differences in the ectopic osteogenic potential of recombinant human BMP adenoviruses |
| Q35629594 | Regional gene therapy to enhance bone repair |
| Q33819873 | Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3. |
| Q34218552 | Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease |
| Q58806285 | Sertoli Cells Engineered to Express Insulin to Lower Blood Glucose in Diabetic Mice |
| Q33826170 | Sustained expression of insulin by a genetically engineered sertoli cell line after allotransplantation in diabetic BALB/c mice |
| Q44133482 | T Helper 17 Promotes Induction of Antigen-Specific Gut-Mucosal Cytotoxic T Lymphocytes following Adenovirus Vector Vaccination |
| Q37209562 | Targeted gene insertion for molecular medicine |
| Q36011728 | The potential of gene therapy for fracture healing in osteoporosis |
| Q36694952 | Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells |
| Q33851759 | Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. |
| Q45885438 | Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector |
| Q81838768 | Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes |
| Q45862335 | Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration |
| Q45859390 | Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA. |
| Q34207596 | Viral vectors for dendritic cell-based immunotherapy |
| Q37569631 | Viral vectors for vascular gene therapy |
Search more.